Ehrlichiosis and anaplasmosis
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
History and exam
Key diagnostic factors
common
presence of risk factors
Key risk factors include tick bite or exposure, male sex, and immunosuppression. Infection tends to be more severe in patients over 60 years of age.[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com
fever
One of the most common constitutional symptoms and generally has an abrupt onset.
May or may not be associated with rigors.
Lasts for 10 to 14 days without antibiotic treatment.[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [99]Eng TR, Harkess JR, Fishbein DB, et al. Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA. 1990 Nov 7;264(17):2251-8. http://www.ncbi.nlm.nih.gov/pubmed/2214103?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com
Present in 99% of human monocytotropic/monocytic ehrlichiosis (HME) cases and 93% of human granulocytotropic/granulocytic anaplasmosis (HGA) cases. Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
headache
One of the most common constitutional symptoms and may be severe.
Present in 64% of human monocytotropic/monocytic ehrlichiosis (HME) cases and 76% of human granulocytotropic/granulocytic anaplasmosis (HGA) cases. Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
malaise
One of the most common constitutional symptoms.
Persists for months after acute disease.
Present in 53% of human monocytotropic/monocytic ehrlichiosis (HME) cases and 94% of human granulocytotropic/granulocytic anaplasmosis (HGA) cases. Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
myalgia
One of the most common constitutional symptoms.
Present in 53% of human monocytotropic/monocytic ehrlichiosis (HME) cases and 77% of human granulocytotropic/granulocytic anaplasmosis (HGA) cases. Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
arthralgia
One of the most common constitutional symptoms.
Present in 43% of human monocytotropic/monocytic ehrlichiosis (HME) cases and 46% of human granulocytotropic/granulocytic anaplasmosis (HGA) cases. Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
nausea
One of the most common constitutional symptoms.
Present in 48% of human monocytotropic/monocytic ehrlichiosis (HME) cases and 38% of human granulocytotropic/granulocytic anaplasmosis (HGA) cases. Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
uncommon
small erythematous lesion with or without necrotic centre
On examination of the skin, a small round erythematous lesion with or without a small necrotic dark centre (eschar) may be seen (tick bite).
[Figure caption and citation for the preceding image starts]: Tick bite at later stage with central necrosis (dark area around tick bite) surrounded by a markedly erythematous areaCourtesy of Lucas Blanton, MD [Citation ends].
non-specific rash
One of the more infrequent constitutional symptoms in adults, but more common in children.
Can be macular, maculopapular, or petechial, and occur anywhere on the body. [Figure caption and citation for the preceding image starts]: Erythematous macular rash involving the lower extremity in a paediatric case of human monocytotropic/monocytic ehrlichiosisCourtesy of Edwin Masters, MD [Citation ends].
Present in 28% (adults) and 67% (children) of human monocytotropic/monocytic ehrlichiosis (HME) cases and 6% of human granulocytotropic/granulocytic anaplasmosis (HGA) cases. Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
Other diagnostic factors
uncommon
vomiting
One of the more infrequent constitutional symptoms.
Present in 36% of human monocytotropic/monocytic ehrlichiosis (HME) cases and 26% of human granulocytotropic/granulocytic anaplasmosis (HGA) cases. Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
diarrhoea
One of the more infrequent constitutional symptoms.
Present in 21% of human monocytotropic/monocytic ehrlichiosis (HME) cases and 16% of human granulocytotropic/granulocytic anaplasmosis (HGA) cases. Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
abdominal pain
One of the more infrequent constitutional symptoms.
Present in 18% of human monocytotropic/monocytic ehrlichiosis (HME) cases. Not reported in human granulocytotropic/granulocytic anaplasmosis (HGA). Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
cough
One of the more infrequent constitutional symptoms.
Present in 23% of human monocytotropic/monocytic ehrlichiosis (HME) cases and 19% of human granulocytotropic/granulocytic anaplasmosis (HGA) cases. Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
dyspnoea
One of the more infrequent constitutional symptoms.
Present in 16.5% of human monocytotropic/monocytic ehrlichiosis (HME) cases. Not reported in human granulocytotropic/granulocytic anaplasmosis (HGA). Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
stiff neck
One of the more infrequent neurological symptoms.
Present in 21% of human granulocytotropic/granulocytic anaplasmosis (HGA) cases. Not reported in human monocytotropic/monocytic ehrlichiosis (HME). Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
confusion
One of the more infrequent neurological symptoms.
Present in 22.4% of human monocytotropic/monocytic ehrlichiosis (HME) cases and 17% of human granulocytotropic/granulocytic anaplasmosis (HGA) cases. Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
photophobia
One of the more infrequent neurological symptoms.
Present in 17% of human monocytotropic/monocytic ehrlichiosis (HME) cases. Not reported in human granulocytotropic/granulocytic anaplasmosis (HGA). Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
stupor
Central nervous system complications are more common in human monocytotropic/monocytic ehrlichiosis (HME).
Present in 4% of HME cases. Not reported in human granulocytotropic/granulocytic anaplasmosis (HGA). Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
coma
Central nervous system complications are more common in human monocytotropic/monocytic ehrlichiosis (HME).
Present in 4% of HME cases. Not reported in human granulocytotropic/granulocytic anaplasmosis (HGA). Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
seizures
Central nervous system complications are more common in human monocytotropic/monocytic ehrlichiosis (HME).
Present in 4% of HME cases. Not reported in human granulocytotropic/granulocytic anaplasmosis (HGA). Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
lymphadenopathy
Rarely seen on physical examination.
Present in 27% of human monocytotropic/monocytic ehrlichiosis (HME) cases. Not reported in human granulocytotropic/granulocytic anaplasmosis (HGA). Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
jaundice
Rarely seen on physical examination.
Present in 15% of human monocytotropic/monocytic ehrlichiosis (HME) cases. Not reported in human granulocytotropic/granulocytic anaplasmosis (HGA). Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
hepatomegaly
Rarely seen on physical examination.
More common in children.
Present in 9% (adults) and 25% (children) of human monocytotropic/monocytic ehrlichiosis (HME) cases. Not reported in human granulocytotropic/granulocytic anaplasmosis (HGA). Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
splenomegaly
Rarely seen on physical examination.
Present in 9% (adults) and 25% (children) of human monocytotropic/monocytic ehrlichiosis (HME) cases. Not reported in human granulocytotropic/granulocytic anaplasmosis (HGA). Unknown occurrence in human ewingii ehrlichiosis (HEE).[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com [66]Weil AA, Baron EL, Brown CM, et al. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012 Mar;87(3):233-9. http://www.ncbi.nlm.nih.gov/pubmed/22386178?tool=bestpractice.com [69]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com [70]Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis. 2000 Aug;31(2):554-60. http://www.ncbi.nlm.nih.gov/pubmed/10987720?tool=bestpractice.com [72]Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med. 1996 Dec 1;125(11):904-8. http://www.ncbi.nlm.nih.gov/pubmed/8967671?tool=bestpractice.com [80]Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure: diagnosis using polymerase chain reaction. Ann Intern Med. 1994 May 1;120(9):730-5. http://www.ncbi.nlm.nih.gov/pubmed/8147545?tool=bestpractice.com [100]Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol. 2003 Sep;10(5):891-6. https://journals.asm.org/doi/10.1128/CDLI.10.5.891-896.2003 http://www.ncbi.nlm.nih.gov/pubmed/12965923?tool=bestpractice.com [101]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222.
secondary infections
Candidiasis, cytomegalovirus, and aspergillosis may be seen in severe cases of human monocytotropic/monocytic ehrlichiosis (HME) and human granulocytotropic/granulocytic anaplasmosis (HGA).
Risk factors
strong
tick bite/exposure
Ehrlichiosis has a seasonal distribution that coincides with higher tick activity in warmer months (e.g., April through to September in the US), when people tend to spend more time outdoors.
Infections can be seen in other months, albeit with less frequency. Cases outside this period occur in lower latitudes with mild winters.
Human monocytotropic/monocytic ehrlichiosis (HME) occurs mostly across the south central and south-eastern states, although cases have been reported in almost all states.[21]Centers for Disease Control and Prevention. Tickborne diseases of the United States: a reference manual for health care providers. 6th ed. Atlanta (GA): U.S Department of Health and Human Services, Centers for Disease Control and Prevention; 2022. Human granulocytotropic/granulocytic anaplasmosis (HGA) occurs mostly across north-eastern states, the Upper Mid-west, and the Pacific North-west.[21]Centers for Disease Control and Prevention. Tickborne diseases of the United States: a reference manual for health care providers. 6th ed. Atlanta (GA): U.S Department of Health and Human Services, Centers for Disease Control and Prevention; 2022.
Tick attachment has to last for 24 to 48 hours for disease to occur. Incubation time is 1 to 2 weeks after tick bite. Tick bite does not always result in disease.
Although a strong risk factor, lack of a tick bite history cannot exclude diagnosis in patients with signs, symptoms, and investigation results consistent with tick-borne illness.
immunosuppression
Associated with more severe disease in human monocytotropic/monocytic ehrlichiosis (HME) and human granulocytotropic/granulocytic anaplasmosis (HGA).[57]Thomas LD, Hongo I, Bloch KC, et al. Human ehrlichiosis in transplant recipients. Am J Transplant. 2007 Jun;7(6):1641-7. https://www.amjtransplant.org/article/S1600-6135(22)02776-9/fulltext#secsect0065 http://www.ncbi.nlm.nih.gov/pubmed/17511689?tool=bestpractice.com Most cases of human ewingii ehrlichiosis (HEE) occur in immunosuppressed patients.[4]Buller RS, Arens M, Hmiel SP, et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med. 1999 Jul 15;341(3):148-55. http://www.nejm.org/doi/full/10.1056/NEJM199907153410303#t=article http://www.ncbi.nlm.nih.gov/pubmed/10403852?tool=bestpractice.com [58]Paddock CD, Folk SM, Shore GM, et al. Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis. 2001 Nov 1;33(9):1586-94. http://www.ncbi.nlm.nih.gov/pubmed/11568857?tool=bestpractice.com [59]Safdar N, Love RB, Maki DG. Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient. Emerg Infect Dis. 2002;8:320-323. http://wwwnc.cdc.gov/eid/article/8/3/01-0249_article.htm
In patients with HIV/AIDS, 70% of cases of HME occurred in patients with CD4+ count <200 cells/microlitre, and infections tend to be more severe with a more frequent risk of complications.[57]Thomas LD, Hongo I, Bloch KC, et al. Human ehrlichiosis in transplant recipients. Am J Transplant. 2007 Jun;7(6):1641-7. https://www.amjtransplant.org/article/S1600-6135(22)02776-9/fulltext#secsect0065 http://www.ncbi.nlm.nih.gov/pubmed/17511689?tool=bestpractice.com Sulfonamides used in these patients have been reported to aggravate infection.[60]Peters TR, Edwards KM, Standaert SM. Severe ehrlichiosis in an adolescent taking trimethoprim-sulfamethoxazole. Pediatr Infect Dis J. 2000 Feb;19(2):170-2. http://www.ncbi.nlm.nih.gov/pubmed/10694012?tool=bestpractice.com
Overall case-fatality rates for immunosuppressed patients with any type are about 25%. All reported fatal cases in HIV/AIDS are due to HME.[4]Buller RS, Arens M, Hmiel SP, et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med. 1999 Jul 15;341(3):148-55. http://www.nejm.org/doi/full/10.1056/NEJM199907153410303#t=article http://www.ncbi.nlm.nih.gov/pubmed/10403852?tool=bestpractice.com [57]Thomas LD, Hongo I, Bloch KC, et al. Human ehrlichiosis in transplant recipients. Am J Transplant. 2007 Jun;7(6):1641-7. https://www.amjtransplant.org/article/S1600-6135(22)02776-9/fulltext#secsect0065 http://www.ncbi.nlm.nih.gov/pubmed/17511689?tool=bestpractice.com [58]Paddock CD, Folk SM, Shore GM, et al. Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis. 2001 Nov 1;33(9):1586-94. http://www.ncbi.nlm.nih.gov/pubmed/11568857?tool=bestpractice.com
age over 60 years
Infection tends to be more severe in patients aged over 60 years.[16]Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis. 2003 Dec;9(12):1579-86. http://www.ncbi.nlm.nih.gov/pubmed/14720399?tool=bestpractice.com [61]Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/2809255?tool=bestpractice.com [62]Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1989 Nov;160(5):803-9. http://www.ncbi.nlm.nih.gov/pubmed/8604172?tool=bestpractice.com [63]Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis. 1998;27:1314-1317. http://www.ncbi.nlm.nih.gov/pubmed/9827289?tool=bestpractice.com
male sex
More common in males due to greater participation in outdoor activities.
Use of this content is subject to our disclaimer